SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001477932-21-001014
Filing Date
2021-02-22
Accepted
2021-02-22 17:14:45
Documents
2
Period of Report
2021-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bicx_8k.htm 8-K 33897
2 FORM OF GALLIGAN DIRECTOR AGREEMENT bicx_ex101.htm EX-10.1 36899
  Complete submission text file 0001477932-21-001014.txt   72230
Mailing Address 2390 EAST ORANGEWOOD AVENUE SUITE 500 ANAHEIM CA 92806
Business Address 2390 EAST ORANGEWOOD AVENUE SUITE 500 ANAHEIM CA 92806 (714) 462-4880
BioCorRx Inc. (Filer) CIK: 0001443863 (see all company filings)

IRS No.: 900967447 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-54208 | Film No.: 21661381
SIC: 8093 Services-Specialty Outpatient Facilities, NEC